This inventor holds 1 USPTO granted patent. Top assignee: Kukje Pharma Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Sooin Chae: Innovator in Pharmaceutical Composition
Introduction
Sooin Chae is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic potential.
Latest Patents
Sooin Chae holds a patent for an indole carboxamide derivative and a pharmaceutical composition containing the same. This patent describes indole carboxamide compounds of Formula (II) or pharmaceutically acceptable salts that inhibit the production of prostaglandin E (PGE) through the inhibition of microsomal prostaglandin E synthase-1 (mPGES-1). The compounds and their salts are effective in treating or preventing various conditions, including inflammation, arthritis, high fever, pain, cancer, stroke, and brain diseases such as Alzheimer's disease. A pharmaceutical composition that includes the indole carboxamide compound as an active ingredient is also part of this patent.
Career Highlights
Sooin Chae is associated with Kukje Pharma Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His research and development efforts have led to advancements in the treatment of serious health conditions.
Collaborations
Sooin Chae collaborates with talented individuals in his field, including Younghoon Kim and Juhee Lee. Their combined expertise contributes to the success of their projects and the advancement of pharmaceutical research.
Conclusion
Sooin Chae is a prominent inventor whose work in pharmaceutical compositions has the potential to impact the treatment of various diseases significantly. His innovative approach and dedication to research continue to drive advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile